amsacrine has been researched along with Primary Myelofibrosis in 1 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
Primary Myelofibrosis: A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.
Excerpt | Relevance | Reference |
---|---|---|
"Amsacrine and VP-16 were given without success." | 2.38 | Acute megakaryoblastic leukemia: a case report. ( Donhuijsen-Ant, R; Leder, LD; Löffler, H; Schadeck-Gressel, C; Schmidt, U; Westerhausen, M, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Donhuijsen-Ant, R | 1 |
Schadeck-Gressel, C | 1 |
Schmidt, U | 1 |
Löffler, H | 1 |
Westerhausen, M | 1 |
Leder, LD | 1 |
1 review available for amsacrine and Primary Myelofibrosis
Article | Year |
---|---|
Acute megakaryoblastic leukemia: a case report.
Topics: Acid Phosphatase; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyta | 1990 |